Amendments for: 172-2023-2024-Q2-1008613

Current (Dec 7, 2023)

Agreement Value: $162,000.00
Agreement: Feasibility - Development of mutanoma vaccines (1008613). Aug 14, 2023 - Dec 31, 2024
Description:

Development of a curative cancer vaccine platform to elicit a personalized immune response against cancer cells

Expected Results:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Organization: National Research Council Canada
Recipient: Angany inc. (For-profit organization)
Location: Quebec, Quebec, CA G1R 1R2
Type: Contribution
Additional Information:

This agreement has been amended 1 time(s). The end date of this agreements has been modified by 61 days.

Federal Riding Name: Québec (24059)
Program Name: Industrial Research Assistance Program – Contributions to Firms

Coverage: IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code: 325410

Amendment 01 (Dec 7, 2023)

Agreement Value:
Organization: National Research Council Canada
Recipient: -
Type: -
Additional Information:

This agreement has been amended 1 time(s). The end date of this agreements has been modified by 61 days.

Amendment 00

Agreement Value: $162,000.00
Agreement: Feasibility - Development of mutanoma vaccines (1008613). Aug 14, 2023 - Oct 31, 2024
Description:

Development of a curative cancer vaccine platform to elicit a personalized immune response against cancer cells

Expected Results:

Organization: National Research Council Canada
Recipient: Angany inc. (For-profit organization)
Location: Quebec, Quebec, CA G1R 1R2
Type: Contribution
Federal Riding Name: Québec (24059)
Program Name: Industrial Research Assistance Program – Contributions to Firms

Coverage: IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code: 325410